The Cooper Companies, Inc. (NASDAQ:COO) Shares Purchased by Amalgamated Bank

Amalgamated Bank grew its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 1.6% in the 1st quarter, HoldingsChannel.com reports. The fund owned 38,686 shares of the medical device company’s stock after acquiring an additional 597 shares during the period. Amalgamated Bank’s holdings in Cooper Companies were worth $3,263,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of COO. KBC Group NV boosted its position in shares of Cooper Companies by 1.2% in the first quarter. KBC Group NV now owns 251,968 shares of the medical device company’s stock worth $21,253,000 after buying an additional 3,045 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Cooper Companies by 15.1% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company’s stock worth $2,194,000 after acquiring an additional 3,440 shares during the period. Diversified Trust Co grew its position in Cooper Companies by 12.5% in the first quarter. Diversified Trust Co now owns 10,229 shares of the medical device company’s stock valued at $863,000 after acquiring an additional 1,135 shares in the last quarter. Bessemer Group Inc. raised its stake in shares of Cooper Companies by 1.8% during the first quarter. Bessemer Group Inc. now owns 1,830,561 shares of the medical device company’s stock valued at $154,408,000 after purchasing an additional 32,228 shares during the period. Finally, Lecap Asset Management Ltd. lifted its position in shares of Cooper Companies by 72.8% during the first quarter. Lecap Asset Management Ltd. now owns 20,662 shares of the medical device company’s stock worth $1,743,000 after purchasing an additional 8,707 shares in the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have weighed in on COO. Piper Sandler reissued an “overweight” rating and issued a $105.00 price objective (down from $115.00) on shares of Cooper Companies in a research report on Friday, May 30th. JPMorgan Chase & Co. restated a “neutral” rating and set a $76.00 price objective (down previously from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. BNP Paribas upgraded Cooper Companies to a “hold” rating in a report on Thursday, March 13th. Stifel Nicolaus cut their price objective on Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a research note on Friday, March 7th. Finally, Robert W. Baird cut their price target on Cooper Companies from $107.00 to $97.00 and set an “outperform” rating on the stock in a report on Friday, May 30th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $99.70.

Cooper Companies Stock Down 0.0%

Shares of COO opened at $73.01 on Friday. The business’s 50 day simple moving average is $75.62 and its 200-day simple moving average is $83.33. The Cooper Companies, Inc. has a one year low of $65.00 and a one year high of $112.38. The company has a market capitalization of $14.60 billion, a P/E ratio of 35.44, a PEG ratio of 1.79 and a beta of 0.99. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping the consensus estimate of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The company had revenue of $1 billion for the quarter, compared to analysts’ expectations of $995.12 million. During the same quarter in the prior year, the business earned $0.85 earnings per share. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. As a group, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.